Deutsche Bank
MBX icon

Deutsche Bank’s MBX Biosciences MBX Stock Holding History

Deutsche Bank’s Portfolio MBX Stock Details MBX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$3.88M Buy
66,122
+34,429
+109% +$2.16M ﹤0.01% 1405
2026
Q2 		$1.75M Buy
31,693
+8,743
+38% +$305K ﹤0.01% 1983
2026
Q1 		$685K Buy
22,950
+2,923
+15% +$99.4K ﹤0.01% 2409
2025
Q4 		$632K Buy
20,027
+9,104
+83% +$221K ﹤0.01% 2448
2025
Q3 		$191K Buy
10,923
+2,161
+25% +$28.9K ﹤0.01% 3084
2025
Q2 		$100K Hold
8,762
– – ﹤0.01% 3257
2025
Q1 		$64.7K Buy
8,762
+4,424
+102% +$46.8K ﹤0.01% 3319
2024
Q4 		$79.9K Buy
+4,338
New +$92.5K ﹤0.01% 3347

Other funds holding MBX

Aaron Wealth Advisors
Aaron Wealth Advisors Chicago, Illinois $2.04B AUM 32.69% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return
Candriam SCA
Candriam SCA Strassen, Luxembourg, Luxembourg $22.5B AUM 50.38% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $551B AUM 33.95% 1-Year Est. Return
Barclays
Barclays London, United Kingdom $500B AUM 36.84% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $608B AUM 32.77% 1-Year Est. Return
ALPS Advisors
ALPS Advisors Denver, Colorado $21.8B AUM 17.58% 1-Year Est. Return
Sowell Financial Services
Sowell Financial Services North Little Rock, Arkansas $3.12B AUM 22.73% 1-Year Est. Return
Russell Investments Group
Russell Investments Group London, United Kingdom $114B AUM 33.83% 1-Year Est. Return
Creative Planning
Creative Planning Overland Park, Kansas $179B AUM 16.96% 1-Year Est. Return

Deutsche Bank's MBX Position: Q3 2026 in Review

Deutsche Bank increased its MBX Biosciences (MBX) stake by 109% in Q3 2026, buying an estimated $2.16M and bringing the position to 66,122 shares worth $3.88M. The position accounts for ﹤0.01% of the portfolio, ranked #1405.

Deutsche Bank first reported a position in MBX in Q4 2024 and has held it in 8 quarters since. 59 funds tracked by Wall St. Rank hold MBX as of Q3 2026.

  • Deutsche Bank held 66,122 shares of MBX Biosciences worth $3.88M as of Q3 2026.
  • Deutsche Bank bought 34,429 MBX Biosciences shares in Q3 2026, an estimated $2.16M.
  • MBX Biosciences made up ﹤0.01% of Deutsche Bank's portfolio in Q3 2026, its #1405 holding.
  • Deutsche Bank first reported a position in MBX Biosciences in Q4 2024 and has held it in 8 quarters since.
  • 59 funds tracked by Wall St. Rank held MBX Biosciences as of Q3 2026.

Based on Deutsche Bank's 13F filing for Q3 2026, filed 6 Nov 2026.